Skip to content

Pilot-trial of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia

Comparison of Emotion-focused Cognitive Behavior Therapy for Patients With Schizophrenia With Standard Treatment: Effects on Psychological Parameters and Rehospitalisation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02787122
Acronym
CBT-E
Enrollment
64
Registered
2016-06-01
Start date
2014-01-01
Completion date
2017-12-31
Last updated
2020-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Delusional Disorder, Schizoaffective Disorder, Brief Psychotic Disorder, Schizophreniform Disorder

Keywords

Schizophrenia, psychotic disorders, Cognitive Behavior Therapy, emotion regulation, self-esteem, randomized-controlled trial

Brief summary

The present study is a pilot single-blind randomized controlled therapy study. Its aim is to assess the efficacy of an emotion-focussed form of Cognitive behavior Therapy that focusses on emotional processes that are involved in the formation and maintenance of delusions such as emotional stability, emotion regulation and self-esteem.

Detailed description

Cognitive Behavior Therapy for psychosis (CBTp) is an effective treatment for patients with psychosis. Several meta-analyses showed an effect of CBTp in addition to antipsychotic treatment of small to medium effect size with regard to positive symptoms, general psychopathology and depression. Nevertheless, present research suggests that are especially emotional processes are closely related to positive symptoms and delusions, such as negative emotions, low self-esteem, depression and anxiety, whereas present interventions of CBTp focus often especially on cognitive interventions in order to change delusions as well as more cognitive risk factors for delusions such as reasoning biases and a dysfunctional causal attribution style. Thus, the aim of the present single-blind randomized-controlled pilot therapy study was to assess the efficacy of a new form of emotion-focussed Cognitive behavior therapy for psychosis with regard to change in positive symptoms and delusions in comparison to standard treatment. The main hypotheses are: \- Efficacy of CBT-E: patients with schizophrenia who receive CBT-E show a more pronounced reduction of delusions (primary outcome), as well as a more pronounced reduction of positive symptoms, depression and general psychopathology, a stronger improvement in general and social functioning and will receive lower doses of antipsychotic medication (secondary outcomes) at post-treatment.

Interventions

BEHAVIORALCBT-E

Patients receive 25 sessions of individual emotion-focused Cognitive Behavior Therapy based on a manual. Interventions aim on patients' mood by implementing positive activities in their daily routine. Further, patients train to reduce worrying behavior. Social contacts are fostered as well. Later, patients are informed on emotions and train emotion regulation strategies. Finally, the focus of CBT-E is on self-acceptance.Patients receive psychoeducation on self-acceptance and learn strategies in order to reduce negative self-schema and foster positive self-schema.

BEHAVIORALTreatment as Usual

Patients receive standardized treatment. After a waiting period of six month, patients receive CBT-E

Sponsors

University of Hamburg-Eppendorf
CollaboratorOTHER
Philipps University Marburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Blinded rating of diagnostic interviews

Intervention model description

The CBT-E group receives 15-25 sessions of cognitive behavior therapy with a special focus on emotion regulation (CBT-E), the wait list group receives CBT-E after six month waiting time

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of schizophrenia, schizoaffective disorder, delusional disorder or brief psychotic disorder * Positive and Negative Syndrome Scale score in item P1 (delusions) of at least two * fluent in German language * agree to participate * estimated general intelligence of at least 70 (assessed with the German Wortschatztest (MWT-B) * no present suicidality

Exclusion criteria

* acute suicidality * comorbid diagnosis of borderline personality disorder and/or substance use disorder in the last six month * intake of Benzodiazepines

Design outcomes

Primary

MeasureTime frameDescription
Change in Psychotic Rating Scale (PSYRATS) delusions scaleChange between assessment pre-therapy and assessment after six month of therapyAssessment of delusion frequency, delusion distress, conviction and loss of quality of life

Secondary

MeasureTime frameDescription
Change in Positive and Negative Syndrome Scale (PANSS)Change between assessment pre-therapy and assessment after six month of therapyAssessment of positive, negative and general symptoms of schizophrenia
Change in Role Functioning Scale (RFS)Change between assessment pre-therapy and assessment after six month of therapyAssessment of social functioning
Change in Calgary Depression Rating Scale for Schizophrenia (CDSS)Change between assessment pre-therapy and assessment after six month of therapyAssessment of depressive symptoms in patients with schizophrenia
Change in Beck Depression Inventory-IIChange between assessment pre-therapy and assessment after six month of therapyAssessment of self-reported depressive symptoms
Change in Peters et al. Delusions InventoryChange between assessment pre-therapy and assessment after six month of therapyAssessment of self-rated delusion frequency, delusional distress and delusional
Change in Paranoia Checklist (PCL)Change between assessment pre-therapy and assessment after six month of therapyAssessment of self-reported paranoid delusion frequency, distress and conviction

Other

MeasureTime frameDescription
Change in Self-Compassion Scale (SCS)Change between assessment pre-therapy and assessment after six month of therapyAssessment of self-reported self-compassion
Change in Reactions to paranoid thoughts Scale (REPT)Change between assessment pre-therapy and assessment after six month of therapyAssessment of cognitive and emotional reactions on paranoid thoughts
Change in Brief Core Schema Scale (BCSS)Change between assessment pre-therapy and assessment after six month of therapyAssessment of positive and negative self-schemas and positive and negative schemas of other persons
Change in Symptom Checklist 9 (SCL-9)Change between assessment pre-therapy and assessment after six month of therapyAssessment of severity of self-reported symptoms of different mental disorders (depression, anxiety, phobia, obsessive-compulsive symptoms, etc.)
Change in Satisfaction With Life Scale (SWLS)Change between assessment pre-therapy and assessment after six month of therapyAssessment of life satisfaction
Change in Pittsburg Sleep Quality Inventory (PSQI)Change between assessment pre-therapy and assessment after six month of therapyAssessment of objective sleep quality and sleep problems
Change in number of social contacts (SozE)Change between assessment pre-therapy and assessment after six month of therapyAssessment of number of social contacts in the last week
Change in Perseverative Thinking Questionnaire (PTQ)Change between assessment pre-therapy and assessment after six month of therapyAssessment of self-reported perseverative thinking and worrying
Change in Scale of Emotion Regulation Competencies (SEK-27)Change between assessment pre-therapy and assessment after six month of therapyAssessment of self-reported habitual use of different emotion regulation strategies

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026